Viewing Study NCT00673205


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2025-12-31 @ 2:12 PM
Study NCT ID: NCT00673205
Status: COMPLETED
Last Update Posted: 2010-12-10
First Post: 2008-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module